arbutamine


Also found in: Wikipedia.

arbutamine

 [ahr-bu´tah-mēn″]
a synthetic catecholamine used as a diagnostic aid in cardiac stress testing in patients unable to exercise sufficiently for the test; administered as the hydrochloride salt.

arbutamine

/ar·but·amine/ (ahr-bu´tah-mēn″) a synthetic catecholamine used as a diagnostic aid in cardiac stress testing in patients unable to exercise sufficiently for the test; administered as the hydrochloride salt.

arbutamine

[ahr-bu′tah-mēn′]
a synthetic catecholamine used as a diagnostic aid in cardiac stress testing in patients unable to exercise sufficiently for the test; it is administered as the hydrochloride salt.
References in periodicals archive ?
The GenESA System combines arbutamine and a computer- controlled drug administration system designed to pharmacologically stress the heart to aid in the diagnosis of coronary artery disease.
NASDAQ: GNSA) today announced that data from Phase 2 clinical trials and one preclinical study with arbutamine (a drug which is part of the GenESA System) have been published in circulation and are scheduled to be presented by researchers from The Netherlands, UCLA Medical Center and the San Diego V.
The GenESA System, which combines arbutamine and a computer-controlled, closed-loop drug delivery device, is being developed to administer a pharmacological stress test to enhance the diagnosis and evaluation of coronary artery disease when used in conjunction with electrocardiography (ECG), echocardiography and radionuclide imaging.
Gensia Sicor will also receive contract manufacturing revenues related to the final production of the drug, arbutamine HC1 injection, for use with the GenESA System.
The GenESA Device delivers arbutamine to the patient intravenously and automatically adjusts the rate of infusion in order to obtain the desired heart rate profile necessary for the physician to make a diagnosis.
The GenESA System combines a novel drug, arbutamine, and a computer-controlled, closed-loop drug administration system designed to pharmacologically stress the heart to aid in the diagnosis of coronary artery disease when used in conjunction with certain stress testing techniques.
The GenESA System combines arbutamine, a potent beta-agonist, with a novel computer-controlled drug administration system for use in the diagnosis of coronary artery disease in conjunction with ECG, echocardiography and radionuclide imaging for patients who cannot exercise adequately.
The safety profile of the GenESA System demonstrated in clinical testing indicates that arbutamine is generally well tolerated.
claiming the composition of matter for arbutamine, the drug component of its GenESA(R) System.
and Gensia engineers, delivers arbutamine to the patient intravenously, automatically adjusting the rate of infusion through a closed-loop mechanism in order to obtain the desired heart rate profile necessary for the physician to make a diagnosis.
The GenESA System combines arbutamine and a computer-controlled drug administration system designed to pharmacologically stress the heart to aid in the diagnosis of coronary artery disease when used in conjunction with electrocardiography, echocardiography and radionuclide imaging.
NASDAQ: GNSA) announced today that clinical data from Phase 3 multicenter international clinical trials with arbutamine and the GenESA(R) System used in conjunction with echocardiography and radionuclide perfusion imaging have been published in abstract form in the February issue of the Journal of the American College of Cardiology.